Experimental research has shown that mice lacking FGF23 exhibit hyperphosphatemia, hypercalcemia, ectopic calcification, and osteoporosis, whereas mice overexpressing FGF23 exhibit hypophosphatemia, rickets, and osteomalacia15. This evidence concerns the gene FGF23 and hyperphosphatemia.